Line 1: |
Line 1: |
| Also known as '''''FeLV | | Also known as '''''FeLV |
| | | |
− | ====Antigenicity==== | + | ==Introduction== |
− | *Main envelope protein: gp70
| |
− | *3 antigenic subgroups:
| |
− | *Group A
| |
− | **is transmitted between cats
| |
− | **is monotypic: one vaccine covers all isolates
| |
− | **causes '''lymphosarcoma'''
| |
− | *Group B:
| |
− | **is recombinant with transmissible FeLV-A
| |
− | **increases the chance of '''thymic tumors'''
| |
− | *Group C:
| |
− | **is a mutant of A
| |
− | **isolates are rare, and occur as A+C mixtures
| |
− | **increases chances of '''anemia'''
| |
| | | |
− | ====Pathogenesis====
| + | ==Pathogenesis== |
| *FeLV is the "disease of friends": transmission usually occurs through '''mutual grooming''' | | *FeLV is the "disease of friends": transmission usually occurs through '''mutual grooming''' |
| *From the oropharynx, virus spreads to most tissues in the body to replicate, notably: | | *From the oropharynx, virus spreads to most tissues in the body to replicate, notably: |
Line 30: |
Line 17: |
| *40% of exposed adults remain healthy and develop Ab and CD8+ Tcells after clearing the virus, without becoming reinfected or silent carriers | | *40% of exposed adults remain healthy and develop Ab and CD8+ Tcells after clearing the virus, without becoming reinfected or silent carriers |
| | | |
− | Clinical Signs: | + | ==Clinical Signs== |
| *'''Leukemia''' | | *'''Leukemia''' |
| *'''Multicentric lymphosarcoma''': B or T cell tumors, which may be palpable as enlarged lymph nodes (particularly mesenteric) | | *'''Multicentric lymphosarcoma''': B or T cell tumors, which may be palpable as enlarged lymph nodes (particularly mesenteric) |
Line 42: |
Line 29: |
| *'''Reproductive failure''': FeLV crosses the placenta, causing fetal resorption or viremic kittens with thymic aplasia | | *'''Reproductive failure''': FeLV crosses the placenta, causing fetal resorption or viremic kittens with thymic aplasia |
| | | |
− | ====Epidemiology====
| + | ==Epidemiology== |
| *Vertical transmission of FeLV-A from mother to kittens either via placenta, grooming, or milk | | *Vertical transmission of FeLV-A from mother to kittens either via placenta, grooming, or milk |
| *Horizontal transmission occurs via saliva during mutual grooming | | *Horizontal transmission occurs via saliva during mutual grooming |
Line 48: |
Line 35: |
| *Particular concern for intensively bred cats because of crowding, etc. | | *Particular concern for intensively bred cats because of crowding, etc. |
| | | |
− | ====Diagnosis==== | + | ==Antigenicity== |
| + | *Main envelope protein: gp70 |
| + | *3 antigenic subgroups: |
| + | *Group A |
| + | **is transmitted between cats |
| + | **is monotypic: one vaccine covers all isolates |
| + | **causes '''lymphosarcoma''' |
| + | *Group B: |
| + | **is recombinant with transmissible FeLV-A |
| + | **increases the chance of '''thymic tumors''' |
| + | *Group C: |
| + | **is a mutant of A |
| + | **isolates are rare, and occur as A+C mixtures |
| + | **increases chances of '''anemia''' |
| + | |
| + | |
| + | ==Diagnosis== |
| *FeLV should be suspect in any cat with '''recurrent bacterial infections''', '''anemia''' or '''weight loss''' | | *FeLV should be suspect in any cat with '''recurrent bacterial infections''', '''anemia''' or '''weight loss''' |
| *'''ELISA''' for '''Antigen''' (capsid protein p27 or envelope protein gp70) | | *'''ELISA''' for '''Antigen''' (capsid protein p27 or envelope protein gp70) |
| *'''Immunochromatography''' is now trusted as ELISA testing can give false positives | | *'''Immunochromatography''' is now trusted as ELISA testing can give false positives |
| *'''Virus isolation''' from heparinised blood can now be performed to confirm a positive diagnosis | | *'''Virus isolation''' from heparinised blood can now be performed to confirm a positive diagnosis |
| + | ELISA |
| + | **Rapid-Immuno-Migration |
| + | **Western Blot |
| + | **Virus Isolation |
| + | **Immunofluorescence |
| + | **PCR |
| | | |
− | ====Control==== | + | ==Infection Control== |
| *Antigen positive sick cats should be destroyed | | *Antigen positive sick cats should be destroyed |
| *Healthy positive cats should have diagnosis confirmed | | *Healthy positive cats should have diagnosis confirmed |
Line 83: |
Line 92: |
| *Cats that are persistently viraemic will progress to develop FeLV-associated diseases | | *Cats that are persistently viraemic will progress to develop FeLV-associated diseases |
| *Some cats will become viraemic again if treated with corticosteroids or stressed if the infection lies dormant in the [[Bone Marrow - Anatomy & Physiology|bone marrow]] | | *Some cats will become viraemic again if treated with corticosteroids or stressed if the infection lies dormant in the [[Bone Marrow - Anatomy & Physiology|bone marrow]] |
− | *Diagnosis:
| + | |
− | **ELISA
| + | ==Treatment== |
− | **Rapid-Immuno-Migration
| |
− | **Western Blot
| |
− | **Virus Isolation
| |
− | **Immunofluorescence
| |
− | **PCR
| |
− | *Treatment:
| |
| **Antibiotics for secondary infection | | **Antibiotics for secondary infection |
| **Anti-retroviral therapy | | **Anti-retroviral therapy |